ng-nitroarginine methyl ester has been researched along with Shock, Cardiogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menon, V | 1 |
| Blatt, A; Cotter, G; Golick, A; Hendler, A; Kaluski, E; Krakover, R; Milo, O; Salah, A; Vered, Z | 1 |
| Blatt, A; Hendler, A; Kaluski, E; Uriel, N | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Shock, Cardiogenic
| Article | Year |
|---|---|
Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock--an update.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Enzyme Inhibitors; Humans; Myocardial Infarction; Myocardial Revascularization; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Risk Assessment; Shock, Cardiogenic | 2006 |
1 trial(s) available for ng-nitroarginine methyl ester and Shock, Cardiogenic
| Article | Year |
|---|---|
LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.
Topics: Aged; Enzyme Inhibitors; Female; Humans; Intra-Aortic Balloon Pumping; Male; Myocardial Infarction; Myocardial Revascularization; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prospective Studies; Shock, Cardiogenic; Survival Analysis; Treatment Outcome | 2003 |
1 other study(ies) available for ng-nitroarginine methyl ester and Shock, Cardiogenic
| Article | Year |
|---|---|
Cardiogenic shock: have we really found the magic potion?
Topics: Adult; Age Factors; Aged; Enzyme Inhibitors; Humans; Intra-Aortic Balloon Pumping; Middle Aged; Myocardial Infarction; Myocardial Revascularization; NG-Nitroarginine Methyl Ester; Nitric Oxide; Randomized Controlled Trials as Topic; Shock, Cardiogenic | 2003 |